What is HRD (Homologous Recombination Deficiency) and how does it impact ovarian cancer?

In this webinar, the Ovacome team are joined by Dr Rowan Miller, Consultant Medical Oncologist specialising in gynae-oncology and early phase clinical trials at University College London and St Bartholomew's Hospitals. Dr Miller provides an overview of what exactly HRD is, and how it can impact ovarian cancers and their treatment.
For ovarian cancer information and support, visit www.ovacome.org.uk/
If you have any questions about ovarian cancer, or want to talk things through, call 0800 008 7054 or email [e-mail] .

[@mjbi]

very clear presentation and concise and succinct answers to questions, great Doctor! I mean there were hardly any 'may be' / 'it depends' / etc. type answers. thanks Doctor!

[@ramprahladprahlad9934]

Good explanation

[@winniethepuuh6969]

Great talk! Can you send me the pdf slides??